Intellia Therapeutics (NTLA) FCF Margin Growth (1y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5,389.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,525.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -341.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 43,511.00
10 Intellia Therapeutics 1.63 Bn 1.63 Bn - 11,587.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11,587.00
Dec 31, 2025 32,783.00
Sep 30, 2025 41,891.00
Jun 30, 2025 11,064.00
Mar 31, 2025 -47,053.00
Dec 31, 2024 -548,172.00
Sep 30, 2024 -18,635.00
Jun 30, 2024 -11,334.00
Mar 31, 2024 47,200.00
Dec 31, 2023 554,368.00
Sep 30, 2023 -16,665.00
Jun 30, 2023 -7,755.00
Mar 31, 2023 -15,538.00
Dec 31, 2022 -24,346.00
Sep 30, 2022 2.26 Mn
Jun 30, 2022 25,827.00
Mar 31, 2022 8,435.00
Dec 31, 2021 14,623.00
Sep 30, 2021 -2.30 Mn
Jun 30, 2021 -123,239.00
Mar 31, 2021 -3,884.00
Dec 31, 2020 -30,810.00
Sep 30, 2020 13,313.00
Jun 30, 2020 60,832.00
Mar 31, 2020 -57,790.00
Dec 31, 2019 -22,415.00
Sep 30, 2019 -5,799.00
Jun 30, 2019 3,465.00
Mar 31, 2019 5,278.00
Dec 31, 2018 40,039.00
Sep 30, 2018 -4,849.00
Jun 30, 2018 6,304.00
Mar 31, 2018 -7,321.00
Dec 31, 2017 -19,990.00
Sep 30, 2017 389.00
Jun 30, 2017 -192,704.00
Mar 31, 2017 39,235.00
Dec 31, 2016 20,474.00
Sep 30, 2016 -3,199.00
Jun 30, 2016 146,145.00
Mar 31, 2016 -91,666.00